114 related articles for article (PubMed ID: 3653195)
1. Differential DNA cross-linking and cytotoxicity in PHA-stimulated human lymphocytes exposed to melphalan, m-L-sarcolysin and peptichemio.
Lewensohn R; Hansson J; Ringborg U; Ehrsson H
Eur J Cancer Clin Oncol; 1987 Jun; 23(6):783-8. PubMed ID: 3653195
[TBL] [Abstract][Full Text] [Related]
2. Increased toxicity and DNA cross-linking by peptide bound m-L-sarcolysin (Peptichemio) as compared to melphalan and m-L-sarcolysin in human melanoma cell lines.
Lewensohn R; Ehrsson H; Hansson J; Ringborg U
Anticancer Res; 1991; 11(1):321-4. PubMed ID: 2018366
[TBL] [Abstract][Full Text] [Related]
3. In vitro cytotoxicity of peptichemio compared to melphalan and meta-DL-sarcolysin.
Morasca L; Erba E
Eur J Cancer (1965); 1980 Aug; 16(8):1105-9. PubMed ID: 7439225
[No Abstract] [Full Text] [Related]
4. Melphalan-induced DNA cross-linking in human melanoma cells and phytohaemagglutinin-stimulated lymphocytes in relation to intracellular drug content and cellular levels of glutathione.
Hansson J; Edgren M; Ehrsson H; Lewensohn R; Ringborg U
Anticancer Res; 1987; 7(1):97-104. PubMed ID: 3566189
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of peptide bound m-L-sarcolysin (peptichemio) on melphalan resistant human myeloma cells in vitro.
Lewensohn R; Fernberg JO; Ehrsson H; Merlini G
Med Oncol Tumor Pharmacother; 1991; 8(4):265-9. PubMed ID: 1820493
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxicity and DNA cross-linking induced by peptide conjugated m-L-sarcolysin in human melanoma cells.
Hansson J; Lewensohn R; Ringborg U
Anticancer Res; 1991; 11(5):1725-30. PubMed ID: 1768043
[TBL] [Abstract][Full Text] [Related]
7. Different melphalan toxicity and DNA cross-linking in human melanoma cells as compared to phytohaemagglutinin-stimulated lymphocytes.
Hansson J; Lewensohn R; Ringborg U
Anticancer Res; 1985; 5(5):471-7. PubMed ID: 4062251
[TBL] [Abstract][Full Text] [Related]
8. DNA-damage in human cells treated with the closely related alkylating agents peptichemio, m-L-sarcolysin and melphalan.
Ringborg U; Lambert B; Lewensohn R; Turesson I
Eur J Cancer Clin Oncol; 1981 Sep; 17(9):991-6. PubMed ID: 7198989
[No Abstract] [Full Text] [Related]
9. The effect of the preparation "Peptichemio" on leukopoiesis and experimental tumours of animals compared with that of sarcolysin and thiophosphamide.
Balitsky KP; Veksler IG; Tsapenko VF; Kavetsky RE
G Ital Chemioter; 1980; 27(1):1-5. PubMed ID: 6793439
[No Abstract] [Full Text] [Related]
10. Antitumor activity of the novel melphalan containing tripeptide J3 (L-prolyl-L-melphalanyl-p-L-fluorophenylalanine ethyl ester): comparison with its m-L-sarcolysin analogue P2.
Gullbo J; Wallinder C; Tullberg M; Lövborg H; Ehrsson H; Lewensohn R; Nygren P; Luthman K; Larsson R
Mol Cancer Ther; 2003 Dec; 2(12):1331-9. PubMed ID: 14707274
[TBL] [Abstract][Full Text] [Related]
11. Melphalan-induced DNA cross-linking and inhibition of DNA and RNA synthesis in human melanoma and lymphoblast cells.
Ringborg U; Hansson J; Jungnelius U; Lewensohn R; Skog S
Anticancer Res; 1990; 10(2A):297-301. PubMed ID: 2346304
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the cytotoxic activity of melphalan with L-prolyl-m-L-sarcolysyl-L-p-fluorophenylalanine in human tumour cell lines and primary cultures of tumour cells from patients.
Larsson R; Dhar S; Ehrsson H; Nygren P; Lewensohn R
Br J Cancer; 1998 Aug; 78(3):328-35. PubMed ID: 9703278
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of the alkylating oligopeptides J1 (L-melphalanyl-p-L-fluorophenylalanine ethyl ester) and P2 (L-prolyl-m-L-sarcolysyl-p-L-fluorophenylalanine ethyl ester): comparison with melphalan.
Gullbo J; Dhar S; Luthman K; Ehrsson H; Lewensohn R; Nygren P; Larsson R
Anticancer Drugs; 2003 Sep; 14(8):617-24. PubMed ID: 14501383
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of T and B lymphoblastic response by mithramycin, dacarbazine, prospidium chloride and peptichemio.
Rojo JM; Ojeda G; Portolés MP; Portolés A
Chemotherapy; 1983; 29(5):345-51. PubMed ID: 6225629
[TBL] [Abstract][Full Text] [Related]
15. Effect of peptichemio and of peptichemio plus hydrocortisone on growth and alkaline phosphatase activity in HeLa cells in vitro.
D'Ancona S; Barberio MT; Adami P; Poltronieri R
Boll Ist Sieroter Milan; 1980 Mar; 59(1):60-9. PubMed ID: 7459015
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of peptichemio in myeloma patients: release of m-L-sarcolysin in vivo and in vitro.
Ehrsson H; Lewensohn R; Wallin I; Hellström M; Merlini G; Johansson B
Cancer Chemother Pharmacol; 1993; 31(4):265-8. PubMed ID: 8422688
[TBL] [Abstract][Full Text] [Related]
17. L-phenylalanine mustard (melphalan) uptake and cross-linking in the RPMI 6410 human lymphoblastoid cell line.
Brox LW; Gowans B; Belch A
Cancer Res; 1980 Apr; 40(4):1169-72. PubMed ID: 7357546
[TBL] [Abstract][Full Text] [Related]
18. Effect of D,L-buthionine-S,R-sulfoximine on cytotoxicity and DNA cross-linking induced by bifunctional DNA-reactive cytostatic drugs in human melanoma cells.
Hansson J; Edgren M; Ehrsson H; Ringborg U; Nilsson B
Cancer Res; 1988 Jan; 48(1):19-26. PubMed ID: 3334994
[TBL] [Abstract][Full Text] [Related]
19. Effect of alpha-difluoromethylornithine on L-phenylalanine mustard-induced cytotoxicity and DNA interstrand cross-linking in a human cell line in vitro.
Ducore JM; McNamara L
Cancer Res; 1986 Mar; 46(3):1068-72. PubMed ID: 3080230
[TBL] [Abstract][Full Text] [Related]
20. Biopharmacokinetic evaluation of peptichemio (PTC) by reversed-phase high-performance liquid chromatography (HPLC): preliminary in vitro studies.
Montaldo P; Perrone F; Cornaglia-Ferraris P
Boll Ist Sieroter Milan; 1987; 66(1):78-85. PubMed ID: 3620124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]